FTO plays a critical role in the progression and metastasis of GC and is associated with low differentiation, lymph node metastasis, TNM stage, and poor prognosis, making it an important molecular marker for monitoring GC (Xu L et al., 2017). This evidence concerns the gene FTO and gastric cancer.